The company will soon submit its ePlex instrument and respiratory pathogen panel for US Food and Drug Administration clearance.
Speakers at the CVS meeting in Florida last week spoke about the utility and effectiveness of sequencing approaches in the study of viruses.
The firm recently made strategic hires with commercialization experience in anticipation of bringing its handheld point-of-care device to market.
The company said sales of its XT-8 molecular diagnostics system were strong, despite a lighter-than-expected flu season.
The state department has implemented WGS protocols for influenza A and B to track drug resistance and to better understand how the virus changes from year to year.
Researchers discussed using WGS to predict antibacterial resistance, to inform influenza vaccine development, and to diagnose and build drug resistance profiles for tuberculosis.
In PLOS this week: role of fibrillarin during henipavirus infection, ancestry patterns in Bene Israel individuals, and more.
The firm's preliminary revenues were lower than expected and led to analyst downgrades and a drop in early trade.
Researchers sequenced seven dozen flu patients to characterize viral genetic diversity and examine viral transmission.
The bank downgraded Quidel's shares to market perform and trimmed its Q4 revenue forecast due to a mild flu season.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.